Skip to main content

Animations

MJFF Publications

7971 - 7980 of 8808 Results
Title
Year
  • Year
  • 2022
  • 2018
  • 2023
  • 2020
  • 2017
  • 2022
  • 2022
  • 2025
  • 2016
  • 2019
  • Summary Details
    RESTRICTED
    Title: Anti-parkinsonian effect of the mGlu2 positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmoset
    Journal Name: European Journal of Pharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ejphar.2022.175429
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Deep Brain Stimulation associated gliosis: A post-mortem study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.04.009
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Microglia-dependent neuroprotective effects of 4-octyl itaconate against rotenone-and MPP+-induced neurotoxicity in Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-023-42813-8
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Soluble TREM2 is elevated in Parkinson’s disease subgroups with increased CSF tau
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awaa021
    Citation Count: 72
  • Summary Details
    OPEN
    Title: Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: Analysis of the PPMI cohort
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.12.006
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Cathepsin B p.Gly284Val Variant in Parkinson’s Disease Pathogenesis
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms23137086
    Citation Count: 16
  • Summary Details
    RESTRICTED
    Title: CRISPR/Cas9‐Based Functional Genomics in Human Induced Pluripotent Stem Cell–Derived Models: Can “the Stars Align” for Neurodegenerative Diseases?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28998
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Fecal tyrosine decarboxylase and motor response complications in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107947
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Neural substrates of excessive daytime sleepiness in early drug naïve Parkinson's disease: A resting state functional MRI study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.01.012
    Citation Count: 46
  • Summary Details
    OPEN
    Title: Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study
    Journal Name: The Lancet Digital Health
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s2589-7500(19)30105-0
    Citation Count: 103
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.